Download presentation
Presentation is loading. Please wait.
1
A.Z. Sint-Blasius, Dendermonde
Real Life Experience of Endovascular first approach in TASC C and D patients after BRAVISSIMO Marc Bosiers Koen Deloose Joren Callaert Imelda Hospital, Bonheiden Patrick Peeters Jürgen Verbist OLV Hospital, Aalst Lieven Maene Roel Beelen R.Z. Heilig Hart, Tienen Koen Deloose, MD Koen Keirse
2
Patient demographics Gender : female Age : 55 years Medical history :
Since 2002: COPD due to nicotine abuse Risk factors : Nicotine abuse (35 pack years) Arterial Hypertension
3
Pre-op symptomatology
Symptoms : Bilateral intermittent claudication with walking distance <50m (Rutherford 3) Duplex US: Impeded flow over the entire femoral tract ABI left = 0.52 ABI right=0.76
4
Pre-op MR Angiography
5
What to do with this type D lesion?
6
TASC II prefers open surgery…
7
People prefer minimally invasive…
8
Brachial access 4F long sheath, 90cm
9
Lesion passage : left leg
0.035 curved stiff nitinol wire 4F Vertebral Glidecath, 120cm
10
Lesion passage : left leg
11
Lesion passage : left leg
12
Lesion passage : left leg
13
Lesion passage : right leg
0.035 curved stiff nitinol wire 4F Vertebral Glidecath, 120cm
14
Lesion passage : right leg
15
Lesion passage : right leg
16
Bilateral femoral retrograde access
17
Bilateral femoral retrograde access
18
Bilateral femoral retrograde access
19
Bifurcation stenting Kissing stents:
2x Omnilink Elite 7.0/59mm balloon expandable stents
20
Bifurcation stenting
21
Bifurcation stenting
22
Bilateral external iliac stenting
2x Absolute Pro 7.0/100mm self-expanding stents
28
Post-op angiographic control
29
Post-op angiographic control
30
Post-op angiographic control
31
Post-op angiographic control
32
…does it work on the long run?
Physician initiated multi-center Belgian-Italian tRial investigating Abbott Vascular Iliac StentS In the treatMent of TASC A, B, C & D iliac lesiOns Omnilink Elite balloon-expandable stent Absolute Pro self-expanding nitinol stent
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.